Abstract
Purpose
The aim of this study was to establish a comprehensive prenatal diagnosis service and to control the birth of thalassemia children in Guangxi Zhuang Automonous Region, China.
Methods
Prenatal diagnosis was performed in 1,058 couples with ‘at risk’ β-thalassemia from Guangxi Zhuang Automonous Region. Fetal samplings were collected by chorionic villus sampling in the first trimester, by amniocentesis in the second trimester and by cordocentesis in the third trimester. DNA analysis was carried out using polymerase chain reaction, reverse dot blot assay, multiplex ligation-dependent probe amplification method and DNA sequencing. Automated high-performance liquid chromatography system was used to analyze the fetal hemoglobin in pregnancies in case mutations were unidentified.
Results
A total of 12 different β-thalassemia mutations were characterized from 2,116 parents. The most common mutation for β-thalassemia was CD41–42 (-CTTT) followed by CD17 (A→T). Prenatal testing revealed 315 normal fetuses, 500 carriers and 253 β-thalassemia major fetuses. The couples having fetuses with β-thalassemia major were counselled to terminate the pregnancies. Postnatal follow-up confirmed all pregnancies.
Conclusion
Our prenatal diagnosis strategy proved to be highly effective in reducing severe thalassemia in pregnant populations.
Similar content being viewed by others
References
Weatherall DJ (2005) Keynote addrees: the challenge of thalassemia for the developing countries. Ann N Y Acad Sci 1054(1):11–17
Weatherall DJ (2008) Hemoglobinopathies worldwide: present and future. Curr Mol Med 8(7):592–599
Alwan A, Modell B (2003) Recommendations for introducing genetics services in developing countries. Nat Rev Genet 4(1):61–68
Modell B, Khan M, Darlison M, King A, Layton M, Old J, Petrou M, Varnavides LA (2001) A national register for surveillance of inherited disorders: beta thalassemia in the United Kindom. Bull World Health Organ 79(11):1006–1013
Pan HF, Long GF, Li Q, Feng YN, Lei ZY, Wei HW, Huang YY, Huang JH, Lin N, Xu QQ, Ling SY, Chen XJ, Huang T (2007) Current status of thalassemia in minority populations in Guangxi, China. Clin Genet 71(5):419–426
Xiong F, Sun M, Zhang X, Cai R, Zhou Y, Lou J, Zeng L, Sun Q, Xiao Q, Shang X, Wei X, Zhang T, Chen P, Xu X (2010) Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region. Clin Genet 78(2):139–148
Weatherall DJ, Clegg JB (2001) The thalassemia syndromes, 4th edn. Blackwell Scientific, Oxford
Cao A, Rosatelli MC, Monni G, Galanello R (2002) Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 29(2):305–308
Old J, Petrou M, Varnavides L, Layton M, Modell B (2000) Accuracy of prenatal diagnosis for haemoglobin disorders in the UK: 25 year’s experience. Prenat Diagn 20(12):986–991
Liao C, Mo QH, Li J, Li LY, Huang YN, Hua L, Li QM, Zhang JZ, Feng Q, Zeng R, Zhong HZ, Jia SQ, Cui YY, Xu XM (2005) Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 25(2):163–171
Willers I, Blankenfeld J, Goedde HW (1990) Characterization of long-term cell cultures of human chorion villi and fibroblasts using antibodies to cytoskeletal proteins. Arch Gynecol Obstet 248(2):87–92
Paul J, Yong MD, Deborah E, Robinson WP (2011) Developmental origin of chorionic villus cultures from spontaneous abortion and chorionic villus sampling. J Obstet Gynaecol Can 33(5):449–452
Milunsky A (1979) Amniotic fluid cell culture. In: Milunsky A (ed) Genetic disorder and the fetus. Plenum Press, New York, pp 75–84
Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO (2001) The amniotic fluid as a source of cells for fetal tissue engineering. J Ped Surgery 36(11):1662–1665
Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 50(10):1736–1747
Official web site for population and family planning of Guangxi Autonomous Region. http://www.gxrkjsw.gov.cn/. Retrieved date March 26, 2008
Angastiniotis MA (1990) Cyprus thalassemia programme. Lancet 336:1119–1120
Cao A, Pintus L, Lecca U, Olla G, Cossu P, Rosatelli C, Galanello R (1984) Control of homozygous β-thalassemia by carrier screening and antenatal diagnosis in Sardinians. Clin Genet 26(1):12–22
Hadji A, Papadakis M, Antsaklis A, Mesoghitis S, Loukopoulos D (1987) Prevention of thalassemia in Greece. II. Prenatal Diagnosis. Paper presented at the Second International Conference on Thalassemia and the Haemoglobinopathies 37 (Abstract RT7-56)
Macer DRJ (1998) Ethics and prenatal diagnosis. In: Milunsky A (ed) Genetic disorders and the fetus: diagnosis, prevention and treatment. John Hopkins University Press, Baltimore, pp 999–1024
Meng DH, Du J, Zhang HY (2011) The security study of 4611 cases of ammioncentesis for prenatal diagnosis. Chin J Birth Health Hered 19(5):52–53
Langlois S, Ford JC, Chitayat D, Désilets VA, Farrell SA, Geraghty M, Nelson T, Nikkel SM et al (2008) Carrier screening for thalassemia and hemoglobinopathies in Canada. J Obstet Gynaecol Can 30(10):950–971
Bouva MJ, Mohrmann K, Brinkman HB, Kemper-Proper EA, Elvers B, Loeber JG, Verheul FE, Giordano PC (2010) Implementing neonatal screening for hemoglobino-pathies in the Netherlands. J Med Screen 17(2):58–65
Acknowledgments
We thank all subjects for participating in our study. The project was partially supported by a grant from the Health Department of Guangxi Province (2012020).
Conflict of interest
All authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, S., Li, D., Lai, Y. et al. Prenatal diagnosis of β-thalassemia in Guangxi Zhuang Autonomous Region, China. Arch Gynecol Obstet 289, 61–65 (2014). https://doi.org/10.1007/s00404-013-2941-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-2941-6